Literature DB >> 15390065

Comparative cognitive effects of bilateral subthalamic stimulation and subcutaneous continuous infusion of apomorphine in Parkinson's disease.

Montse Alegret1, Francesc Valldeoriola, MaJosé Martí, Manuela Pilleri, Carme Junqué, Jordi Rumià, Eduardo Tolosa.   

Abstract

Bilateral subthalamic deep brain stimulation (STN-DBS) and continuous subcutaneous infusion of apomorphine (APM-csi) can provide a comparable improvement on motor function in patients with advanced Parkinson's disease (PD), but the mechanisms by which both therapies exert their effects are different. We analyzed the cognitive effects of APM-csi. We also compared neuropsychological effects induced by STN-DBS and APM-csi in advanced PD to ascertain the neuropsychological aspects relevant in determining the therapeutic procedure that is the most appropriate in a particular patient. We studied 9 patients treated with STN-DBS and 7 patients with APM-csi. Neuropsychological measures included Rey's Auditory-Verbal Learning, Stroop, Trail Making, phonetic verbal fluency, and Judgment of Line Orientation tests. In the APM-csi group, significant changes were not observed in the neuropsychological tests performance. By contrast, in the STN-DBS group, moderate worsening was found in phonetic verbal fluency and Stroop Naming scores that was partially reversible at long-term follow-up and did not have consequences on regular activities. Consequently, these findings could be interpreted as being not relevant in deciding the most suitable treatment in a given patient. 2004 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15390065     DOI: 10.1002/mds.20237

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  18 in total

Review 1.  High frequency deep brain stimulation of the subthalamic nucleus versus continuous subcutaneous apomorphine infusion therapy: a review.

Authors:  R Carron; V Fraix; C Maineri; E Seigneuret; B Piallat; P Krack; P Pollak; A L Benabid; Stéphan Chabardès
Journal:  J Neural Transm (Vienna)       Date:  2010-12-29       Impact factor: 3.575

Review 2.  Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa.

Authors:  Yoland Smith; Thomas Wichmann; Stewart A Factor; Mahlon R DeLong
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

Review 3.  What is the best treatment for fluctuating Parkinson's disease: continuous drug delivery or deep brain stimulation of the subthalamic nucleus?

Authors:  Rüdiger Hilker; Angelo Antonini; Per Odin
Journal:  J Neural Transm (Vienna)       Date:  2010-12-25       Impact factor: 3.575

4.  Clinical and neuropsychological follow up at 12 months in patients with complicated Parkinson's disease treated with subcutaneous apomorphine infusion or deep brain stimulation of the subthalamic nucleus.

Authors:  D De Gaspari; C Siri; A Landi; R Cilia; A Bonetti; F Natuzzi; L Morgante; C B Mariani; E Sganzerla; G Pezzoli; A Antonini
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04       Impact factor: 10.154

Review 5.  Effects of Subthalamic Nucleus Deep Brain Stimulation on Facial Emotion Recognition in Parkinson's Disease: A Critical Literature Review.

Authors:  S Kalampokini; E Lyros; P Lochner; K Fassbender; M M Unger
Journal:  Behav Neurol       Date:  2020-07-17       Impact factor: 3.342

Review 6.  The effect of STN DBS on modulating brain oscillations: consequences for motor and cognitive behavior.

Authors:  Fabian J David; Miranda J Munoz; Daniel M Corcos
Journal:  Exp Brain Res       Date:  2020-06-03       Impact factor: 1.972

Review 7.  Neuropsychiatric effects of subthalamic neurostimulation in Parkinson disease.

Authors:  Jens Volkmann; Christine Daniels; Karsten Witt
Journal:  Nat Rev Neurol       Date:  2010-08-03       Impact factor: 42.937

8.  Cognitive outcome 5 years after bilateral chronic stimulation of subthalamic nucleus in patients with Parkinson's disease.

Authors:  M F Contarino; A Daniele; A H Sibilia; L M A Romito; A R Bentivoglio; G Gainotti; A Albanese
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-05-11       Impact factor: 10.154

9.  Cognitive outcome following bilateral subthalamic nucleus deep brain stimulation for Parkinson's disease-a comparative observational study in Indian patients.

Authors:  Kshiteeja Jain; Remya Ramesh; Syam Krishnan; Krishnakumar Kesavapisharady; K P Divya; Sankara P Sarma; Asha Kishore
Journal:  Acta Neurol Belg       Date:  2021-08-26       Impact factor: 2.396

10.  Effects of STN DBS on memory guided force control in Parkinson's disease (June 2007).

Authors:  Janey Prodoehl; Daniel M Corcos; John C Rothwell; Leo Verhagen Metman; Roy A E Bakay; David E Vaillancourt
Journal:  IEEE Trans Neural Syst Rehabil Eng       Date:  2007-06       Impact factor: 3.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.